‘We’re not doing 30 bets a year’: Vijay Pande on betting small after running $4B at a16z

Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "en...